Abstract CT069: A phase I study of the first-in-class anti-fatty acid oxidation agent, KN510713, in patients with advanced solid cancers
Year: 2025
Type: conference-abstract
Source: Cancer Research
Institutions: National Cancer Center, Seoul National University
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4409822208
